| 000 | 01830 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513144741.0 | ||
| 264 | 0 | _c19980929 | |
| 008 | 199809s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.3109/10428199809050915 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInokuchi, K | |
| 245 | 0 | 0 |
_aMinimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cMay 1998 |
||
| 300 |
_a553-61 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aCore Binding Factor Alpha 2 Subunit |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xpathology |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xgenetics |
| 650 | 0 | 4 |
_aLeukemia, Promyelocytic, Acute _xgenetics |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xanalysis |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 |
_aOncogene Proteins, Fusion _xanalysis |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRUNX1 Translocation Partner 1 Protein |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xanalysis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _xpathology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTranscription Factors _xanalysis |
| 700 | 1 | _aIwakiri, R | |
| 700 | 1 | _aFutaki, M | |
| 700 | 1 | _aHanawa, H | |
| 700 | 1 | _aTanosaki, S | |
| 700 | 1 | _aNomura, T | |
| 700 | 1 | _aDan, K | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 29 _gno. 5-6 _gp. 553-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428199809050915 _zAvailable from publisher's website |
| 999 |
_c9609749 _d9609749 |
||